Daniel Heinrich

[Prof Joe O'Sullivan @ProfJOSullivan]

Our data on prediction of benefit from Radium-223 in #mCRPC @QubPGJCCR #ProEx
published today
https://t.co/o2iqAaoJuN

[OncoAlert @OncoAlert]

HERE IN #APCCC24 🇨🇭
IT'S ALL ABOUT THAT PSMA

@APCCC_Lugano @Silke_Gillessen @AOmlin @neerajaiims @ravikanesvaran @scserendipity1
@EfstathiouEleni @nataliagandur @SandhuShahneen
@ChrisSweens1 @DrSpratticus @soulehoward1
@nealshore @RobertReiterMD @DRathkopf
@ColinCPritchard @piet_ost @WilliamOhMD
@ProfJOSullivan @DrPaulNguyen @NDowJames
@VedangMurthy @declangmurphy @dmukherji
@tompowles1 @brian_rini @mrabti_hind
@CaPsurvivorship @DrRanaMcKay
@MatikainenMika @quimmateo @LoebStacy
@Prof_Nick_James @DrMHofman @montypal
@DrDanielHeng @apolo_andrea
@DrChoueiri @PGrivasMDPhD @TiansterZhang
@HHammersMD @sonpavde @drenriquegrande
@BraunMDPhD @yekeduz_emre @declangmurphy
@GGrisay @fabioturco92

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

#APCCC24 is on the horizon, launching on April 25th!

As a consensus conference, it’s the epicentre for bridging clinical gaps in advanced #prostatecancer care. The world’s experts gather to tackle crucial topics and highlight the evolving dynamics of #PCa treatment.

🌍 With an extensive list of global panel members, #APCCC24 is your gateway to the forefront of oncology. Join us for a HYBRID experience that promises to inspire and inform you.

📢 Act swiftly! Less than a month to go, with special rates available and free online access for participants from lower- and lower-middle-income countries. Don’t miss out on the chance to contribute to the consensus that will drive the future of prostate cancer management.

🔗 Secure your spot, join APCCC 2024 TODAY 👉https://t.co/C9g3kM94Ex

#GlobalOncology #ConsensusConference #OncologyResearch #CountdownToEndCancer
#GlobalHealth #MedicalConference #OncologyInnovation

@Silke_Gillessen @AOmlin @SandhuShahneen @OncoAlert @ChrisSweens1 @DrSpratticus @soulehoward1 @FacsRaja @ravikanesvaran @AnthonyMJoshua @BarbaraJereczek @Prof_Nick_James @DrMHofman @ProfKHerrmann @JGrummet @Nicola_Fossati @a_fatiregun @stefanofanti4 @EfstathiouEleni @ZilliThomas @neerajaiims @scserendipity1 @nataliagandur @tompowles1 @brian_rini @montypal @soulehoward1 @nealshore @charlesryanmd @RobertReiterMD @DRathkopf @ColinCPritchard @PCaParker @ProfPadhani @piet_ost @WilliamOhMD @ProfJOSullivan @DrPaulNguyen @NDowJames @VedangMurthy @declangmurphy @dmukherji @mrabti_hind @morr316 @CaPsurvivorship @amerseburger @DrRanaMcKay @MatikainenMika @quimmateo @LoebStacy

[Daniel Heinrich @docheinrich]

Four hours with Tom and Brian on my ears and this view in front of my eyes! Really exhausting 😎☀️😁 @tompowles1 @brian_rini @Uromigos

[Daniel Heinrich @docheinrich]

Verdens beste kreftbehandling on https://t.co/cDWFgJfxjm https://t.co/Oq9cpdatzB #tidsskriftet via @Tidsskriftet

[Daniel Heinrich @docheinrich]

#APCCC21

[Tom Powles @tompowles1]

Lenvatinib + pembro is at least as active as other VEGF/IO combos. RR of 70% + PFS of 24 mnths (yes 24) are eye catching. OS of 0.66 in line with others. Low LFT AEs is important. Lenvatinib + evero has PFS but not OS signal. It’s role requires definition. ?post cabo/nivo #GU21

[Daniel Heinrich @docheinrich]

Overbevist at det å godkjenne COVID-19 vaksinene nå er riktig og glad for at utviklingen har gått så fort!
Støtter også veldig å flytte helsepersonell frem i prioriteringskøen og skal utvilsomt være en av de første som vaksineres selv når det er min tur! https://t.co/sCiBX6XQ32

[Eurosport Golf @ESN_golf]

SØNDAGSKONK #1: Best siste 6 hull av @McIlroyRory & @JonRahmpga. Retweet for McIlroy, ´like´for Rahm. #ESNgolf @Golfshopen_no

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

Out now! Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 published on @EUplatinum

👉 https://t.co/qRznL9n0rk

#apccc19 #apccc21 #prostatecancer @Els_Urology @urotoday

[Daniel Heinrich @docheinrich]

Getting ready for day 1 #ASCO19

[Eurosport Golf @ESN_golf]

MASTERSKONK LØRDAG: Best siste 9 hull av @TigerWoods & @IanJamesPoulter. Retweet for Tiger, ´like´for Poulter. Poulter-sko i premie! @PerHaugsrud #ESNgolf

[Eurosport Golf @ESN_golf]

MASTERSKONK FREDAG: Best siste 9 hull mellom @TigerWoods & @McIlroyRory. Retweet for Tiger, ´like´for Rory. Lykke til! @PerHaugsrud 👍

[Harald Rex @KongenDin]

Den mest udiskutable fredsprisen på lenge deles ut, men avisene rydder forsidene for Farmen-Kjetil. Det får være måte på forsimpling av offentligheten, @vgnett og @dagbladet. Dette er flaut.

[Daniel Heinrich @docheinrich]

Bent lanserer #ekspertpanelet https://t.co/m7iibGiQ63

[Daniel Heinrich @docheinrich]

Bent lanserer #ekspertpanelet @ Haukeland universitetssjukehus https://t.co/h9K3ZOVxo1

[Daniel Heinrich @docheinrich]

@Prof_Nick_James Thanks for the support! Not everyone agreed.

[Daniel Heinrich @docheinrich]

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pfizer’s Inlyta® (axitinib) Significantly Improved Overall Survival (OS) and Progression-free Survival (PFS) as First-Line Therapy for Advanced or Metastatic Renal Cell Carcinoma | Business Wire https://t.co/TEngTvcxzE

[Nick James @Prof_Nick_James]

Great presentation of our latest #STAMPEDEtrial M1 RT data by @PCaParker Simultaneous publication in @TheLancet Here’s the link https://t.co/UGXQl4MvHk #ESMO18

[Nick James @Prof_Nick_James]

18% had ADT + Doc as their SOC. adding RT to this had a similar HR to the effect of adding RT to ADT monotherapy (slightly bigger in fact). ADT/Doc/RT will be our SOC for this group in future in chemo fit pts